|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000300 USD | 0.00% |
|
0.00% | +50.00% |
| 20/05/24 | Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from S&P TMI Index | CI |
| 16/05/24 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| Capitalization | 350 300.51 281.04 262.55 484.44 31.46K 527.1 3.26K 1.27K 14.91K 1.31K 1.29K 54.73K | P/E ratio 2022 |
-0.18x | P/E ratio 2023 | -0.18x |
|---|---|---|---|---|---|
| Enterprise value | -4.74M -4.07M -3.81M -3.56M -6.57M -426M -7.14M -44.17M -17.21M -202M -17.8M -17.42M -742M | EV / Sales 2022 |
445,103x | EV / Sales 2023 | -62,512x |
| Free-Float |
69.25% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
| Current month | -98.80% | ||
| 1 month | +200.00% | ||
| 6 months | -25.00% | ||
| Current year | +50.00% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0.02 | |
| Current year | 0 | 0.5 | |
| 1 year | 0 | 0.5 | |
| 3 years | 0 | 17.25 | |
| 5 years | 0 | 583.81 | |
| 10 years | 0 | 583.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrés Fajardo
CEO | Chief Executive Officer | 47 | 24/03/2022 |
Henry Hague
DFI | Director of Finance/CFO | 53 | 21/02/2021 |
Julián Wilches
LAW | General Counsel | 46 | 17/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Julien
BRD | Director/Board Member | 55 | 17/12/2020 |
Andrés Fajardo
BRD | Director/Board Member | 47 | 30/11/2020 |
| Director/Board Member | 69 | 17/12/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -98.91% | -100.00% | 526 | ||
| -0.21% | -1.82% | -19.09% | -32.65% | 6.4B | ||
| -0.09% | -1.17% | +43.12% | +52.72% | 4.33B | ||
| +1.33% | -0.17% | -17.66% | +24.29% | 4.35B | ||
| +0.23% | -6.38% | +4.14% | -65.39% | 4.16B | ||
| +1.13% | +0.40% | -8.73% | -9.59% | 3.61B | ||
| +0.26% | -1.36% | +5.11% | +29.40% | 3.22B | ||
| -0.24% | -2.59% | -2.88% | -36.60% | 2.47B | ||
| +0.33% | -2.08% | +9.25% | -1.96% | 1.97B | ||
| +0.14% | -1.71% | +0.92% | +58.24% | 1.75B | ||
| Average | +0.29% | -0.90% | -8.47% | -8.16% | 3.23B | |
| Weighted average by Cap. | +0.32% | -0.95% | +0.08% | -2.48% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 17.8 15.28 14.29 13.35 24.64 1.6K 26.81 165.73 64.58 758.39 66.8 65.38 2.78K | 17.42 14.95 13.99 13.07 24.11 1.57K 26.23 162.16 63.19 742.07 65.36 63.97 2.72K |
| Net income | -66.17M -56.81M -53.13M -49.63M -91.58M -5.95B -99.64M -616M -240M -2.82B -248M -243M -10.35B | -17.9M -15.37M -14.37M -13.43M -24.77M -1.61B -26.96M -167M -64.94M -763M -67.17M -65.74M -2.8B |
| Net Debt | -8.59M -7.38M -6.9M -6.45M -11.89M -772M -12.94M -80.01M -31.17M -366M -32.25M -31.56M -1.34B | -4.74M -4.07M -3.81M -3.56M -6.57M -426M -7.14M -44.17M -17.21M -202M -17.8M -17.43M -742M |
More financial data
* Estimated data
Employees
296
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/12/25 | 0.000300 $ | 0.00% | 1,989 |
| 08/12/25 | 0.000300 $ | 0.00% | 866 |
Delayed Quote OTC Markets, December 09, 2025 at 06:02 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- CLVR Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















